BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12025827)

  • 41. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.
    Wiersma JE; van Schaik DJ; van Oppen P; McCullough JP; Schoevers RA; Dekker JJ; Blom MB; Maas K; Smit JH; Penninx BW; Beekman AT
    BMC Psychiatry; 2008 Mar; 8():18. PubMed ID: 18366729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patients' interpersonal problems as moderators of depression outcomes in a randomized controlled trial comparing mindfulness-based cognitive therapy and a group version of the cognitive-behavioral analysis system of psychotherapy in chronic depression.
    Probst T; Schramm E; Heidenreich T; Klein JP; Michalak J
    J Clin Psychol; 2020 Jul; 76(7):1241-1254. PubMed ID: 31997369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nefazodone, psychotherapy, and their combination for chronic depression.
    Umanoff DF
    N Engl J Med; 2000 Oct; 343(14):1041; author reply 1042-3. PubMed ID: 11023392
    [No Abstract]   [Full Text] [Related]  

  • 45. Nefazodone, psychotherapy, and their combination for chronic depression.
    Duncan BL; Miller SD
    N Engl J Med; 2000 Oct; 343(14):1042; author reply 1042-3. PubMed ID: 11023393
    [No Abstract]   [Full Text] [Related]  

  • 46. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
    Maddux RE; Riso LP; Klein DN; Markowitz JC; Rothbaum BO; Arnow BA; Manber R; Blalock JA; Keitner GI; Thase ME
    J Affect Disord; 2009 Oct; 117(3):174-9. PubMed ID: 19217168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nefazodone, psychotherapy, and their combination for chronic depression.
    Rubin RT
    N Engl J Med; 2000 Oct; 343(14):1041; author reply 1042-3. PubMed ID: 11023391
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E; Kriston L; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Bausch P; Fangmeier T; Meister R; Berger M; Hautzinger M; Härter M
    JAMA Psychiatry; 2017 Mar; 74(3):233-242. PubMed ID: 28146251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
    J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient treatment preference as a predictor of response and attrition in treatment for chronic depression.
    Steidtmann D; Manber R; Arnow BA; Klein DN; Markowitz JC; Rothbaum BO; Thase ME; Kocsis JH
    Depress Anxiety; 2012 Oct; 29(10):896-905. PubMed ID: 22767424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mixed anxiety and depression in older adults: clinical characteristics and management.
    Cassidy EL; Lauderdale S; Sheikh JI
    J Geriatr Psychiatry Neurol; 2005 Jun; 18(2):83-8. PubMed ID: 15911936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.
    Schramm E; Kriston L; Elsaesser M; Fangmeier T; Meister R; Bausch P; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Löwe B; Walter H; Wolf M; Domschke K; Berger M; Hautzinger M; Härter M
    Psychother Psychosom; 2019; 88(3):154-164. PubMed ID: 31121581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effectiveness of the cognitive behavioral analysis system of psychotherapy for chronic depression: a randomized controlled trial.
    Wiersma JE; Van Schaik DJ; Hoogendorn AW; Dekker JJ; Van HL; Schoevers RA; Blom MB; Maas K; Smit JH; McCullough JP; Beekman AT; Van Oppen P
    Psychother Psychosom; 2014; 83(5):263-9. PubMed ID: 25116461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
    Sánchez-Lacay JA; Lewis-Fernández R; Goetz D; Blanco C; Salmán E; Davies S; Liebowitz M
    Depress Anxiety; 2001; 13(3):118-24. PubMed ID: 11387731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive-Behavioral Analysis System of Psychotherapy, Drug, or Their Combination for Persistent Depressive Disorder: Personalizing the Treatment Choice Using Individual Participant Data Network Metaregression.
    Furukawa TA; Efthimiou O; Weitz ES; Cipriani A; Keller MB; Kocsis JH; Klein DN; Michalak J; Salanti G; Cuijpers P; Schramm E
    Psychother Psychosom; 2018; 87(3):140-153. PubMed ID: 29847831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH; Ravindran A
    J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New strategies for treating chronic depression.
    Kocsis JH
    J Clin Psychiatry; 2000; 61 Suppl 11():42-5. PubMed ID: 10926054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.